Globus Medical Stock Analysis (NYSE:GMED)

Add to My Stocks
$32.29 $0.33 (1.01%) GMED stock closing price Jul 21, 2017 (Closing)
Watch Robo Advisor Video of GMED Stock Analysis
Globus Medical
Updated on : Jul 21, 2017
previous close
GMED 32.3 (0%)
S&P 500 2472.5 (0%)
Closing Price On: Jul 21, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Instruments
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q1
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
26.1%
Sector Average:
-0.5%
5 Quarter Net Profit
Net Margins
2017-Q1
%
LTM Margin
Compared to the industry
Cash Flow
Operating cash flow:
$53.4M
Net Income:
$28.7M
PROS      CONS
Operating Margins
Net Margins
Cash Flow
ROIC
ROE
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
GMED PS :
5.3
Industry PS :
5.2
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
19.9%
Return on Equity:
13%
Free Cash Flow Margin:
26.9%
Double Tap To Exit Full Screen
0:00
/

Globus Medical Analysis Video

114 5 2

View Globus Medical stock analysis video. This is our GMED analyst opinion covering the buy and sell arguments for GMED stock.

Globus Medical Inc Stock Rating (4/5)

Our Globus Medical stock opinion is based on fundamentals of the company. This Globus Medical stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy GMED stock?

  • Globus Medical's average operating margin of 26.1% was exceptional.
  • LTM Net margins were good at 18.1% for Globus Medical.
  • The company has an operating cash flow which is 1.9 times the net income.
  • Globus Medical generates a high return on invested capital of 19.9%.
  • Return On Equity (ROE) which is a measure of the company's profitability, looks great for Globus Medical at 13%.
  • The company has a good Free Cash Flow (FCF) margin of 26.9%.

Should you sell GMED stock?

Comments on this video and Globus Medical stock